News (36)

Transcript : Acerus Pharmaceuticals Corporation - Shareholder/Analyst Call
Acerus Announces Definitive Agreement to Acquire Serenity LLC and the Global Rights to Noctiva™ AQ
Transcript : Acerus Pharmaceuticals Corporation - Shareholder/Analyst Call
Bank of Montreal : BMO's Mona Malone Wins 2021 Report on Business Best Executive Award AQ
Acerus Pharmaceuticals : Announces Details of Previously Completed Rights Offering BU
TMX : Committee to Chart the Future of Corporate Governance in Canada PU
Transcript : Acerus Pharmaceuticals Corporation, Q1 2020 Earnings Call, May 12, 2020
Acerus Pharmaceuticals : Appoints Dr. Geoff Cotton to Its Board of Directors PU
Acerus Pharmaceuticals Corporation announced that it has received CAD 4.530001 million in funding from First Generation Capital Inc. CI
Acerus Pharmaceuticals : Announces Executive Leadership Change BU
Trimel Pharmaceuticals : Acerus Appoints Mr. Mark Lievonen to its Board of Directors PU
Trimel Pharmaceuticals : Acerus Announces Voting Results for the 2017 Annual General Meeting PU
Acerus Appoints Mr. Luc Mainville to Its Board of Directors BU
Acerus Announces Voting Results for the 2016 Annual General Meeting BU
First Generation Capital Inc. Enters Into Agreement to Purchase Common Shares of Acerus Pharmaceuticals Corporation MW
Acerus Announces Changes to Board of Directors BU
Trimel Pharmaceuticals : Announces Voting Results For 2015 Annual General And Special Shareholder's Meeting PU
Trimel Pharmaceuticals : Announces Voting Results for 2015 Annual General and Special Shareholder’s Meeting BU
Trimel Pharmaceuticals : Reports Third Quarter 2014 Financials Results PU
Trimel Pharmaceuticals : Reports Third Quarter 2014 Financial Results MW
First Generation Capital Inc. Converts a Portion of Previously Issued Convertible Note of Trimel Pharmaceuticals Corporation MW
Trimel Pharmaceuticals : Provides Corporate Update and Second Quarter 2014 Financial Results MW
First Generation Capital Inc. Amends Previously Issued Convertible Note of Trimel Pharmaceuticals Corporation MW
Trimel Pharmaceuticals : Completes Private Placement Of Common Shares PU
First Generation Capital Inc. Acquires Convertible Note of Trimel Pharmaceuticals Corporation MW
Trimel Pharmaceuticals : Announces Voting Results For 2014 Annual General And Special Shareholders’ Meeting PU
Trimel Pharmaceuticals : Announces Voting Results for 2014 Annual General and Special Shareholders' Meeting MW
Trimel Reports Fourth Quarter and Full Year 2013 Financial Results MW
First Generation Capital Inc. Acquires Shares of Trimel Pharmaceuticals Corporation MW
Trimel Announces $10.5 Million Private Placement of Common Shares MW
Trimel Announces Appointment of Tom Rossi to Its Board of Directors MW
Trimel Announces Retirement of Chair and Appointment of New Chair MW
Trimel Pharmaceuticals Corporation Announces Board Changes, Effective from January 15, 2014 CI
First Generation Capital Inc. Acquires Shares of Trimel Pharmaceuticals Corporation MW
Trimel Pharmaceuticals Corporation Announces Appointment Ian Ihnatowycz to Board of Directors CI
Ian O. Ihnatowycz to Step Down from AGF Management Limited as Director, Effective May 7, 2013 CI

Companies (1)

B2EN CO., LTD. 36 M $
Logo B2En Co., Ltd.

B2En Co Ltd, formerly Sangsangin Ian No.1 Special Purpose Acquisition Co Ltd is a Korea-based company principally engaged in the data consulting and data solution business. The Company operates its business through three segments. The Big Data segment eng ...


Insiders

Picture Ian Ihnatowycz
Ian Ihnatowycz

Ian Orest Ihnatowycz was the founder of Acuity Investment Management, Inc. (founded in 1990) where he held the title of President & Chief Executive Officer from 1991 to 2010.
He is currently the President & Chief Executive Officer at Generation Capital, Inc. (since 2011), First Generation Capital, Inc. (since 2011), and Chairman at Acerus Pharmaceuticals Corp.
(since 2014).
He also serves as a Director at Kardium, Inc., The Atlantic Council of the United States, The Royal Conservatory of Music, Real Imaging Holdings Ltd., Myca Health Inc., Real Imaging Ltd., Fulcrum Management Solutions Ltd., Wellbox, Inc., and IKOMED Technologies, Inc. Mr. Ihnatowycz previously held the position of President & Chief Executive Officer at Acuity Growth & Income Trust, Acuity Small Cap Corp., and Acuity Funds Ltd.
(from 1990 to 2011).
He also served as a Director at AGF Management Ltd., Zymeworks BC, Inc., and The Investment Funds Institute of Canada.
Mr. Ihnatowycz obtained his undergraduate degree from the University of Toronto in 1971 and an MBA from the Richard Ivey School of Business.





Picture Ian Epstein
Ian Epstein

Ian Epstein is currently the President at Enigma Securities Ltd.
He previously worked as a Portfolio Manager at CommonWealth Opportunity Capital GP LLC.
Mr. Epstein received an undergraduate degree from the University of California, Berkeley.





Picture Ian Kardian Suwarganda
Ian Kardian Suwarganda

Ian Kardian Suwarganda served as the Chief Executive Officer and Executive Director at Nippecraft Ltd.
before pursuing further education.
He holds an undergraduate degree from the University of California, Berkeley and an MBA from INSEAD.


No results for this search

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW